Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hansson

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
Scientific Reports|November 26, 2022
Succinate prodrugs in combination with atropine and pralidoxime protect cerebral mitochondrial function in a rodent model of acute organophosphate poisoningSarah Piel, Joanna I Janowska, J Laurenson Ward, et al.
Journal of Internal Medicine|February 20, 2014
Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survivalJ Hansson, M R Galanti, M-P Hergens, et al.
Molecular and Cellular Biochemistry|October 25, 2022
Succinate prodrugs as treatment for acute metabolic crisis during fluoroacetate intoxication in the ratSarah Piel, Joanna I Janowska, J Laurenson Ward, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2017
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trialN Basset-Séguin, A Hauschild, R Kunstfeld, et al.
Iscience|February 18, 2026
The succinate prodrug NV354 prevents brain lesions and late-stage motor dysfunction in mitochondrial complex I deficiencyMeagan J McManus, Yi Zhu, Cesar Alves, et al.
The EMBO Journal|February 21, 2015
The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1βHidetoshi Fujita, Naoko Yagishita, Satoko Aratani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsL Kandolf Sekulovic, K Peris, A Hauschild, et al.
Journal of the National Cancer Institute|September 30, 2010
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL studyF Demenais, H Mohamdi, V Chaudru, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Scientific Reports|November 26, 2022
Succinate prodrugs in combination with atropine and pralidoxime protect cerebral mitochondrial function in a rodent model of acute organophosphate poisoningSarah Piel, Joanna I Janowska, J Laurenson Ward, et al.
Journal of Internal Medicine|February 20, 2014
Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survivalJ Hansson, M R Galanti, M-P Hergens, et al.
Molecular and Cellular Biochemistry|October 25, 2022
Succinate prodrugs as treatment for acute metabolic crisis during fluoroacetate intoxication in the ratSarah Piel, Joanna I Janowska, J Laurenson Ward, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2017
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trialN Basset-Séguin, A Hauschild, R Kunstfeld, et al.
Iscience|February 18, 2026
The succinate prodrug NV354 prevents brain lesions and late-stage motor dysfunction in mitochondrial complex I deficiencyMeagan J McManus, Yi Zhu, Cesar Alves, et al.
The EMBO Journal|February 21, 2015
The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1βHidetoshi Fujita, Naoko Yagishita, Satoko Aratani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsL Kandolf Sekulovic, K Peris, A Hauschild, et al.
Journal of the National Cancer Institute|September 30, 2010
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL studyF Demenais, H Mohamdi, V Chaudru, et al.
Pageof 21